Home・Listă Acțiuni・Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc

Deschisă

SectorSănătate

479.27 2.4

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

460.59

Maxim

482.2

Indicatori cheie
By Trading Economics
Venit	-36M -94M
Vânzări	-9.7M 311M
EPS	-1.38
Marjă de profit	-30.318
Angajați	915
EBITDA	-36M -86M

Recomandări
By TipRanks
Recomandări	Puternic Cumpărare
Prognoză pe 12 luni	+47.64% upside

Dividende
By Acuity
Următoarele câștiguri	3 nov. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	751M 13B
Deschiderea anterioară	476.87
Închiderea anterioară	479.27

Sentimentul știrilor

By Acuity

32%

68%

78 / 340 Clasament în Healthcare

Madrigal Pharmaceuticals Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

31 iul. 2026, 23:06 UTC

Madrigal Pharmaceuticals Inc shares are lower in after-market hours with no specific news identified. The stock remains near the lower end of its one-month range.

30 iul. 2026, 19:27 UTC

News

Madrigal Pharmaceuticals shares are lower following a widened second-quarter net loss of $57.9 million and increased operating expenses of $420.6 million.

29 iul. 2026, 22:26 UTC

Madrigal Pharmaceuticals shares are lower in after-market hours, reflecting broader market volatility following the Federal Reserve's interest rate decision and inflation concerns.

28 iul. 2026, 18:46 UTC

Madrigal Pharmaceuticals is lower today, continuing a broader decline since Monday's close. No specific news has been identified to explain the movement.

27 iul. 2026, 23:56 UTC

Madrigal Pharmaceuticals Inc is trading higher in after-market hours, reflecting a notable increase since Monday's close, despite no specific news identified.

20 iul. 2026, 16:02 UTC

Social Media

Madrigal Pharmaceuticals is lower today amid aggressive call buying and heightened market volume, with broader inflation concerns influenced by geopolitical tensions.

Comparație

Modificare preț

Madrigal Pharmaceuticals Inc Așteptări

Obiectiv de preț

By TipRanks

47.64% sus

Prognoză pe 12 luni

Medie 689.93 USD 47.64%

Maxim 964 USD

Minim 543 USD

În baza a 14 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruMadrigal Pharmaceuticals Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

14 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 14 analiști care au acordat evaluări ale acțiunilor Madrigal Pharmaceuticals Inc - Dist în ultimele 3 luni.

Sentiment

By Acuity

78 / 340 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania.